AI Tools Have Improved Detection of Alzheimer’s Therapy Side Effects
A new medical panel suggests that artificial intelligence can better identify ARIA in patients using anti-amyloid treatments.
Updated on Sept. 23, 2026 in Alzheimer’s
Live Poll
Would you trust an AI tool to assist your doctor in interpreting a medical scan?
A multidisciplinary panel has released new recommendations supporting the conditional use of AI to help radiologists identify amyloid-related imaging abnormalities (ARIA) during Alzheimer’s therapy. These tools may help clinicians manage the increased volume of MRI scans required for patient monitoring.
Why it matters
Anti-amyloid treatments carry risks of conditions like edema and microhemorrhages, creating a need for frequent, high-volume imaging. Using AI in this process aims to reduce diagnostic fatigue and the risk of missed abnormalities as patient monitoring needs surge.
A panel of neuroradiologists and clinicians published findings in the American Journal of Roentgenology noting that AI assistance improves diagnostic sensitivity for ARIA-E and ARIA-H. However, researchers observed a reduction in specificity, and clinical outcomes remain under investigation.
The players
American Journal of Roentgenology
A peer-reviewed scientific journal that publishes research and clinical guidelines in the field of diagnostic radiology.
The details
AI tools function by flagging potential signs of ARIA, such as vasogenic edema or microhemorrhages, on MRI scans. The panel recommends a radiologist-in-the-loop framework, requiring doctors to validate all AI outputs against clinical context. Successful integration also relies on standardized imaging protocols and ongoing quality assurance audits at local sites.
Timeline
September 17, 2026: The panel published its official recommendations in the American Journal of Roentgenology.
Health Landscape
These recommendations address the growing demand for MRI monitoring, which is projected to reach 7 to 8 million additional examinations annually. This approach updates the standard of care by institutionalizing human-AI collaboration in neuroradiology.
If you are undergoing anti-amyloid therapy, your treatment plan will likely include frequent MRI scans to monitor for potential side effects. It is worth discussing with your doctor whether your care facility utilizes AI-assisted imaging and how this technology supports your safety.
The takeaway
AI assistance may help radiologists manage the high volume of monitoring required during Alzheimer's treatment, though it does not replace expert clinical oversight. Always speak with your neurologist or care team about how your imaging data is reviewed for signs of ARIA.
Further reading
For more information on the current standard of care and managing treatment, visit the Alzheimer’s section.
Live Poll
Would you trust an AI tool to assist your doctor in interpreting a medical scan?
